U01AI145965
Cooperative Agreement
Overview
Grant Description
Pna nanoparticles for gene editing in vivo
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Connecticut
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 284% from $421,111 to $1,617,042.
Yale Univ was awarded
PNA Nanoparticles for Gene Editing In Vivo
Cooperative Agreement U01AI145965
worth $1,617,042
from the National Institute of Allergy and Infectious Diseases in July 2019 with work to be completed primarily in Connecticut United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 5/20/24
Period of Performance
7/5/19
Start Date
6/30/23
End Date
Funding Split
$1.6M
Federal Obligation
$0.0
Non-Federal Obligation
$1.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01AI145965
Transaction History
Modifications to U01AI145965
Additional Detail
Award ID FAIN
U01AI145965
SAI Number
U01AI145965-2093846852
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NM00 NIH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
FL6GV84CKN57
Awardee CAGE
4B992
Performance District
CT-90
Senators
Richard Blumenthal
Christopher Murphy
Christopher Murphy
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,650,695 | 100% |
Modified: 5/20/24